Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

Clinical trial NCT04575584 · TERMINATED

Trial details

NCT number: NCT04575584
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Coronavirus Disease (COVID-19)

Start date: 2020-10-19
Primary completion: 2021-08-11
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.